Quick Takeaways
- Susan Molineaux has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $14,609.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Susan Molineaux
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Susan Molineaux is at least $14,609 dollars as of 22 May 2025. Susan Molineaux is the PRESIDENT & CEO, Director of Calithera Biosciences, Inc. and owns shares of Calithera Biosciences, Inc. stock worth about $14.6K.
- Signature
- Scott A. Samuels, attorney-in-fact for Susan Molineaux
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Susan Molineaux and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Calithera Biosciences, Inc. ($14,609).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Susan Molineaux
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CALA | Calithera Biosciences, Inc. | PRESIDENT & CEO, Director | $14,609 | 23 Jan 2023 | ||
| CYT | Cyteir Therapeutics, Inc. | Director | 03 Feb 2023 | |||
| GERN | GERON CORP | Director | 21 May 2025 | |||
| RPTX | Repare Therapeutics Inc. | Director | 17 Jun 2024 |
Insider Transactions Reported by Susan Molineaux:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.